Rfp Financial Group LLC Novartis Ag Transaction History

Rfp Financial Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$92.57 - $107.37 $9,071 - $10,522	-98 Reduced 2.9%	3,286 $349,000
Q1 2024 May 09, 2024	BUY	$95.27 - $108.47 $19,720 - $22,453	207 Added 6.52%	3,384 $327,000
Q2 2023 Aug 01, 2023	BUY	$92.52 - $104.91 $222,048 - $251,784	2,400 Added 308.88%	3,177 $320,000
Q1 2023 Apr 26, 2023	SELL	$80.03 - $92.81 $192,072 - $222,744	-2,400 Reduced 75.54%	777 $71.5 Million
Q4 2022 Jan 24, 2023	BUY	$75.55 - $92.52 $240,022 - $293,936	3,177 New	3,177 $288 Million

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Rfp Financial Group LLC, based on Form 13F filings with the SEC.

Stay updated on Rfp Financial Group LLC with notifications on news.